Back to all news

AI Advances and Governance Drive Oncology Innovation at MSK

EurekAlertResearch
AI Advances and Governance Drive Oncology Innovation at MSK

Memorial Sloan Kettering researchers report advancements in AI governance, biomarker analysis, and language models for improved cancer care.

Key Details

  • 1MSK implemented governance covering 26 AI models, two ambient pilots, and 33 nomograms, demonstrating scalable AI oversight.
  • 2AI tool EAGLE analyzed over 8,000 lung cancer slides, reducing molecular testing by over 40% while maintaining standards.
  • 3A cancer-trained LLM ('Woollie') was built from 40,000+ radiology reports; achieved predictive scores of 97 (MSK) and 88 (UCSF) overall.
  • 4Study on 118 nonagenarians showed lung cancer surgery can be safe and effective, with no patients dying within 90 days.
  • 5Drug combination shown to induce mutation (MMRd) in colorectal tumors, potentially sensitizing resistant cancers to immunotherapy, but no clinical responses observed yet.

Why It Matters

Robust governance and real-world validation are crucial for integrating AI into oncology workflows. New computational tools, especially those leveraging radiology and pathology data, show promise for improving clinical decision-making and operational efficiency in precision cancer care.

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.